The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically improve ...

Risk factors for postoperative disease recurrence help guide the physician in determining the appropriate treatment strategy after Crohn's disease surgery. The approach to Crohn's disease ...

For many people with Crohn’s disease, reaching remission—when inflammation is no longer detectable—seems like a major victory ...

If you have an inflammatory bowel disease (IBD) like Crohn's disease or ulcerative colitis (UC), you might not feel like eating much after a flare-up. But good nutrition plays an essential role in ...

Amelenodor is under clinical development by AbbVie and currently in Phase I for Crohn's Disease (Regional Enteritis).

MetroCreative Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according ...

Four years ago, over dinner and drinks, five Buckhead moms hatched a bold plan to turn their love of softball into a lifeline for those battling Crohn’s disease.

Remestemcel-L is under clinical development by Mesoblast and currently in Phase III for Crohn's Disease (Regional Enteritis).

Fatigue in IBD 1 year after diagnosis does not appear to be less prevalent even when applying stricter definitions of disease ...